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Abstract
Background: Chikungunya (CHIKV) has recently seen a re-emergence in India with high morbidity. However, the
epidemiology and disease burden remain largely undetermined. A prospective multi-centric study was conducted to
evaluate clinical, epidemiological and virological features of chikugunya infection in patients with acute febrile illness from
various geographical regions of India.
Methods and Findings: A total of 540 patients with fever of up to 7days duration were enrolled at Karnataka Institute of
Medical Sciences (KIMS), Karnataka (South); Sawai Man Singh Medical College (SMS) Rajasthan (West), and All India Institute
of Medical Sciences (AIIMS) New Delhi (North) from June 2008 to May 2009. Serum specimens were screened for
chikungunya infection concurrently through RT-PCR and serology (IgM). Phylogenetic analysis was performed using Bioedit
and Mega2 programs. Chikungunya infection was detected in 25.37% patients by RT-PCR and/or IgM-ELISA. Highest cases
were detected in south (49.36%) followed by west (16.28%) and north (0.56%) India. A difference in proportion of positives
by RT-PCR/ELISA with regard to duration of fever was observed (p,0.05). Rashes, joint pain/swelling, abdominal pain and
vomiting was frequently observed among chikungunya confirmed cases (p,0.05). Adults were affected more than children.
Anti-CHIK antibodies (IgM) were detected for more than 60days of fever onset. Phylogenetic analysis based on E1 gene from
KIMS patients (n=15) revealed ,99% homology clustering with Central/East African genotype. An amino acid change from
lysine to glutamine at position 132 of E1 gene was frequently observed among strains infecting children.
Conclusions: The study documented re-emergence of chikungunya in high frequencies and severe morbidity in south and
west India but rare in north. The study emphasizes the need for continuous surveillance for disease burden using multiple
diagnostic tests and also warrants the need for an appropriate molecular diagnostic for early detection of chikungunya
virus.
Citation: Ray P, Ratagiri VH, Kabra SK, Lodha R, Sharma S, et al. (2012) Chikungunya Infection in India: Results of a Prospective Hospital Based Multi-Centric
Study. PLoS ONE 7(2): e30025. doi:10.1371/journal.pone.0030025
Editor: Aftab A. Ansari, Emory University School of Medicine, United States of America
Received August 23, 2011; Accepted December 12, 2011; Published February 17, 2012
Copyright:  2012 Ray et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: pratimaray.aiims@gmail.com
Introduction
Chikungunya virus (CHIKV) is an enveloped positive-strand
RNA virus belonging to genus Alphavirus of the family Togaviridae
[1,2]. It is an epidemic viral disease responsible for significant
global public health problem mainly in Asian and African
continents [3–9]. Efforts are underway in developing prevention
strategy. Recently a VLP based chikungunya vaccine was
developed in USA that was found to be protective in primates
[10]. Chikungunya infection is generally characterized by fever
and joint pains with additional symptoms including chills,
vomiting, nausea, headache and rashes [11–13].
Historical data report the first detection of chikungunya in 1952
in the Makonde Plateau in Africa [14–15] where the virus is
known to be maintained in the sylvatic cycle of wild primates and
mosquitoes such as Aedes taylori [16–17]. Later in 1958 it was
detected in urban Asia such as Thailand mainly transmitted by
Aedes aegypti [18–20]. In India, where both Aedes aegypti and Aedes
albopictus are known to exist and are widely prevalent during the
post monsoon season, CHIKV was first detected in 1963 in West
Bengal [18]. It was followed by several epidemics in Chennai,
Pondicherry, Vellore, Visakhapatnam, Rajmundry, Kakinada,
Nagpur and Barsi between 1964 and 1973 [21]. Recently CHIKV
resurfaced in India affecting several South Indian states [21,22].
The outbreak started in 2005 from the coastal regions of Andhra
Pradesh and Karnataka [6,23]. With more than 1.3 million people
estimated to be affected CHIKV prevailed across 150 districts of 8
states in India [23]. Despite the number estimated, the actual
disease burden was thought to be much higher due to potential
underestimation from lack of accurate reporting [24].
CHIKV being an RNA virus is susceptible to high mutation
rates which may help the virus to evade the immune response and
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of CHIKV indicates only three lineages with distinct genotypic
and antigenic characteristics i.e. the ‘‘Central/East African
genotype’’, the ‘‘Asian genotype’’ and the ‘‘West African
genotype’’ [25]. CHIKV strains with an Asian genotype of E1
gene were reportedly detected during the 1963–73 outbreaks in
India, while the more recent outbreaks since 2005 have been
caused by the ‘‘Central/East African genotype’’ [21]. Additionally,
a mutation at 226 amino-acid (Valine–Alanine) of E1 gene was
observed during the recent outbreaks and has been associated with
the more efficient replication of CHIKV in Aedes albopictus [26].
The high morbidity and loss in daily activity associated with
CHIKV infection results in considerable economic loss among the
affected nations, specifically India [27]. This emphasizes the need
to have a detailed understanding of epidemiology and strain
diversity for planning a prevention strategy. Towards this end the
present study aimed to evaluate the disease prevalence at various
geographical regions and assess the genomic diversity among
CHIKV strains infecting the Indian population.
Methods
Study sites
Patients were recruited at three distantly located regions of
India (North, West and South) from 1
st June, 2008 through 31
st
May, 2009. Patient enrolment was carried out year round at
Karnataka Institute of Medical Sciences (KIMS), Hubli, Karna-
taka (south); Sawai Man Singh Medical College (SMS) Jaipur,
Rajasthan (West), and All India Institute of Medical Sciences
(AIIMS) New Delhi (north) with AIIMS as the coordinating and
testing centre.
Patients and clinical specimens
Patient enrolment involved those with fever #7 days duration at
the time of their visit to the Out/Inpatient departments at AIIMS
(n=178), KIMS (n=233) and SMS (n=129) hospitals and those
who were willing to participate in the study (n=540). The study
was approved by each Institution’s Ethics Committee (Institutional
Ethics Committee, AIIMS; Ethics Committee SMS Medical
College, Ethics Committee Karnataka Institute of medical
Sciences, Hubli). All patients (or for children parents or guardians)
gave written informed consents. Demographic details, clinical data
including symptoms and onset and duration of fever were
recorded in the specified proforma. Approximately 3 ml of blood
was collected from each patient enrolled at the time of admission.
Convalescent phase (15–90 days of fever onset) sample could be
collected from 30 patients only at KIMS center. Sera were
separated from the blood by centrifugation and stored at 270uC
in aliquots till further use [28]. Specimens from KIMS and SMS
centers were subsequently transferred to AIIMS center within two
to three months of collection. Both RTPCR assay and serology
(IgM) were employed to test CHIKV in all study specimens at the
AIIMS centre.
Diagnostic RT-PCR
Genomic viral RNA from CHIKV infected culture-lysate/
patient sera were extracted using QIA Amp Viral RNA minikit
(QIAGEN, Germany) according to manufacturer’s protocol. The
294b E1 gene fragment of CHIKV was amplified with Qiagen one
Step RT-PCR kit as described previously [29]. Briefly, the RNA
fragment was reverse transcribed and amplified in a single step
and the 294 bp amplified product was analyzed on 2% agarose gel
as reported earlier [29].
IgM-ELISA
All serum specimens were screened for CHIKV specific IgM
antibodies by ELISA using a commercial kit (Standard Diagnos-
tics, Inc., Korea) according to manufacturer’s recommended
procedure.
Nucleotide sequencing
Sequences were determined from the 913 bp E1-amplicon (nt
10246–11158) that had been generated following RT-PCR
(n=15) with forward (59-TACCCATTCATGTGGGGC-39) and
reverse (59-TGACTATGTGGTCCTTCGGGGG-39) primers.
Amplification product was gel purified by the Gene-Clean
purification method (Q-biogene, Cambridge, UK) and sequenced
using a previously described method [30]. Lineage identification
and assessment of evolutionary relationships were performed using
Bioedit and Mega2 programs as described previously [30].
Statistical analysis
Statistical analysis was performed using Stata statistical
software, version 7.0 (StataCorp LP, College Station, TX, USA).
Results
Clinical features among suspected chikungunya patients
Table 1 lists patient demographics from a total of 540 cases with
fever up to 7days duration regardless of chikungunya virus
infection. Among the clinical features recorded, joint pain (62.8%)
and headache (63.3%) were most frequently observed while other
features included abdominal pain (48.1%), vomiting (43.9%), rash
(36.1%), joint swelling (27.8%), cough (27.2%) and restlessness
(21.3%). Symptoms such as diarrhea, rhinitis, conjunctival
congestion, hepatomegaly, splenomegaly and lymphadenopathy
were rarely observed (Table 1). Symptoms commonly caused by
CHIKV i.e. joint pain, joint swelling, abdominal pain and
conjuctival congestions were more common among patients at
KIMS as compared to SMS and AIIMS.
Laboratory based diagnostics of Chikungunya viruses
CHIKV infection was tested both for the presence of anti-
CHIKV IgM antibodies by ELISA and CHIKV RNA by RT-
PCR. A total of 137 (25.4%) subjects tested positive for CHIKV
through either of the two tests. A solitary case was detected at
AIIMS while relatively higher percentages were observed at SMS
(16.3%) and KIMS (49.4%) (Table 2). Rate of chikungunya
detection was nearly similar between ELISA and RT-PCR
(Table 2). Year round detection of chikungunya was observed at
KIMS while at SMS it was rarely detected during summer.
Moreover, majority of the CHIKV cases were observed during
monsoon and post monsoon seasons both at SMS and KIMS.
Time kinetics of CHIKV RNA detection by RT-PCR and
anti-CHIKV IgM antibodies by ELISA
Chikungunya detection was performed by both RT-PCR and
IgM-ELISA with detection rates ranging from 4.3%–90% for RT-
PCR and 10%–95.6% for ELISA depending on the days of fever
onset (Figure 1). This difference in detection rates between RT-
PCR and ELISA with respect to days of fever onset was found to
be statistically significant through chi square analysis (p,0.05).
RT-PCR assay was more sensitive till first 4 days of fever onset
declining after day 4 at which point serology (IgM) was observed to
be more effective (Figure 1).
Additionally 30 cases from KIMS were assessed for persistence
of IgM during convalescence (15–90 days of fever onset). While
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anti-CHIK IgM between 15–90 days post illness, none of the
chikungunya negative patients (n=19) were detected the same
(data not shown).
Association of clinical features with CHIKV laboratory
diagnosis
Comparison of clinical features between chikungunya positive
and negative patients demonstrated rashes, headache, joint pains,
joint swelling, abdominal pain, cough and vomiting to be
significantly associated with CHIKV confirmed cases (p,0.05)
whereas differences for other symptoms were not found significant
(Table 3).
Age wise distribution of CHIKV infection among the
study population
We compared the rate of CHIKV prevalence based on patient
age groups 0–5, .5–18 and .18 years of age and observed
significantly higher detection (p,0.05) among adult populations
(aged .18 years). An apparent increase in frequency of CHIKV
detection with age, from about 16% cases among children to 50%
among adults was observed (Figure 2).
In addition Chi square analysis revealed significant differences
for presence of rashes, headache, joint pain and joint swelling
(p,0.05), between children (,18 years) and adults (.18 years)
(Table 4). Interestingly, while most of the rashes among adult cases
(.18 years) were of erythrematous type, that of children were
maculaopapular type (,18 years) (data not shown).
Phylogenetic tree based on E1 gene of CHIKV
demonstrates high homology with strains belonging to
Central/East African genotype
Comparative sequence analysis of chikungunya E1 gene from
15 CHIKV infected patients from KIMS revealed 98.3%–99.9%
homology among them, clustering within the Central/East African
genotype (Figure 3). Furthermore, all recently detected CHIKV
strains worldwide including India clustered in this lineage with
93.4% to 99.9% homology. However, recently detected CHIKV
Table 1. Clinical features observed among patients (n=540) screened for CHIKV across various regions of India during 2008–2009.
Age, Sex &Clinical features Delhi (n=178) Karnataka (n=233) Rajasthan (n=129) Total (n=540)
Mean Age 6 SD (in years) 10.5168.16 25.75619.88 8.3863.83 16.61616.15
Male 121(68.0) 114(48.9) 94(72.9) 329(60.9)
Rash 20(11.2) 110(47.2) 65(50.4) 195(36.1)
Erythematous 14(7.9) 101(43.3) 50(38.8) 165(30.6)
Maculopapular 12(6.7) 12(5.1) 13(10.1) 37(6.8)
Headache 111(62.4) 179(76.8) 52(40.3) 342(63.3)
Joint pain 81(45.5) 208(89.3) 50(38.8) 339(62.8)
Joint swelling 7(3.9) 119(51.1) 24(18.6) 150(27.8)
Abdominal Pain 65(36.5) 147(63.1) 48(37.2) 260(48.1)
Vomiting 61(34.3) 126(54.1) 50(38.8) 237(43.9)
Diarrhea 13(7.3) 11(4.7) 15(11.6) 39(7.2)
Rhinitis* 20(13.7) 26(25.2) 23(17.8) 69(18.2)
Cough 57(32.0) 50(21.5) 40(31.0) 147(27.2)
Restlessness 9(5.1) 78(33.5) 28(21.7) 115(21.3)
Hess test 22(12.4) 0(0.0) 0(0.0) 22(4.1)
Conjunctival congestion 5(2.8) 42(18.0) 3(2.3) 50(9.3)
Hepatomegaly 4(2.2) 31(13.3) 5(3.9) 40(7.4)
Splenomegaly 3(1.7) 10(4.3) 1(0.8) 14(2.6)
Note. Data are no. (%) of patients.
* Rhinitis was recorded for only 378 cases of which 146,103 and 129 at Delhi, Karnataka and Rajasthan respectively.
doi:10.1371/journal.pone.0030025.t001
Table 2. Serological and genomic based detection of chikungunya infection among 540 clinically suspected cases.
No. (%) of positivity
Study center No. of subjects IgM ELISA RT-PCR (E1 gene) Total positivity
Delhi 178 1 (0.56) - 1 (0.56)
Karnataka 233 52 (22.32) 64 (27.47) 115* (49.36)
Rajasthan 129 16 (12.40) 5 (3.88) 21 (16.28)
All 540 69 (12.78) 69 (12.78) 137* (25.37)
*One sample was positive by both IgM serology & CHIKV E1 RT-PCR.
doi:10.1371/journal.pone.0030025.t002
Chikungunya Infection in India
PLoS ONE | www.plosone.org 3 February 2012 | Volume 7 | Issue 2 | e30025strains from India appeared different from those of previous 1963
and 1973 outbreaks (Figure 3). Results were similar when the
analysis was performed with amino acid sequences deduced from
the E1 gene sequences (data not shown). Additionally we detected
an amino acid change from lysine to glutamine at residue 132 in
E1 gene among 5 of 8 CHIKV infected children, while none
among the adults (data not shown). Of note, all these 15 cases were
enrolled in the same place and during same period.
Discussion
The present multi-centre study confirms and extends the
findings of recent reports from India and other parts of world
indicating a re-emergence of severe chikungunya disease which is
becoming a major public threat in India [25,27]. This is the first
multi-centre study with sites from three distinct geographical
locations except the eastern part of the country. The study was
carried out with year round enrolment of subjects in comparison
to previous CHIKV epidemiological data that was derived mainly
from outbreaks [11,12,31–34]. For the first time both genomic
(RT-PCR) and serology (IgM ELISA) based assays were employed
throughout the study for laboratory confirmation of chikungunya
in a large sample population. However our data on IgM antibody
persistence emphasizes the need to analyze paired sample for IgM
or IgG test for confirmation of chikungunya infection, particularly
for those sampled after day-3 post illness when viremia is low.
Amongst the three centres, AIIMS and SMS had a relatively
higher male:female ratio. However this could be attributed to the
social bias generally observed against females in the north and west
India rather than to disease susceptibility based on gender.
Various other studies conducted worldwide have shown inconsis-
tencies on gender bias to disease susceptibility with most studies
reporting each gender to be equally susceptible [31,35,36].
Discrepancies in the symptoms of Chikungunya among
suspected cases across different studies warrant the requirement
of a clear and well defined clinical profile of the disease. For
Figure 1. Proportion of CHIKV-positivity by RT-PCR or IgM ELISA according to days of fever onset. n denotes the total number of CHIKV
positive cases.
doi:10.1371/journal.pone.0030025.g001
Table 3. Comparison of clinical symptoms between CHIKV-positive subjects and CHIKV-negative subjects.
Clinical features
(Number of patients having the clinical
features)
No (%) Positive by Either
RT-PCR or IgM-ELISA (n=137)
No (%) Negative by both assay
(n=403) P value
a
Rashes (n=195) 68(49.6) 127(31.5) 0.0002
Headache (n=342) 104 (75.9) 238 (59.1) 0.0006
Joint pain (n=339) 117 (85.4) 222 (55.1) ,0.0001
Joint swelling (n=150) 69 (50.4) 81 (20.1) ,0.0001
Abdominal pain (n=260) 86 (62.8) 174 (43.2) 0.0001
Diarrhea (n=39) 5 (3.6) 34 (8.4) .0.05
Cough (n=147) 24 (17.5) 123 (30.5) 0.0045
Vomiting (n=237) 71 (51.8) 166 (41.2) 0.0387
Note. Data are no. (%) of patients.
a: p value was calculated using Chi square test for association of clinical symptoms between CHIKV positive and CHIKV negative cases.
doi:10.1371/journal.pone.0030025.t003
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CHIKV cases as compared to other [12]. One reason for this
discrepancy could be due to the study design. While earlier studies
were retrospective focussing largely on outbreaks, our study was
conducted throughout the year and across different sites.
Our study also demonstrated a link between chikungunya
detection rate and geographical location of study centre. We
observed highest percentage of cases at KIMS which is located
along the coast in the southern part of the country compared to
the other two centres that are landlocked regions with extended
periods of dry summer and extreme winter. This is in agreement
with findings of other studies those reported the prevalence of
chikungunya mostly in the coastal regions including South India
and South East Asia [4–7,23,24,26,27,37,38].
One interesting observation made in the present study was the
near absence of chikungunya case at AIIMS site despite reports of
dengue prevalence [39]. As both dengue and chikungunya are
transmitted by the same vectors, it is not unreasonable to expect
similar disease prevalence. However reports of the Delhi State
Government showed large number of dengue cases in Delhi during
2008, while only few clinically suspected chikungunya cases were
reported [40]. Similarly a study from Delhi detected CHIKV virus
in serum samples of patients hospitalized during a dengue outbreak
in the year 2006 [41]. Since then no confirmed cases of CHIKV
infections have been reported from Delhi. One can speculate the
reason for the absence of chikungunya to be simply a time factor
and that in time CHIKV may make its way from the coastal regions
to more inland areas such as Delhi. Hence, this warrants year round
surveillanceof CHIKVinregionsthat already have high prevalence
of dengue. Beside the geographical location another reason for the
lower detection of chikungunya could be due to silent infections that
may have gone unnoticed in the past and thus may have primed the
immune system against this pathogen. A study from Chennai,
nearly a decade prior to the 1964 outbreak, observed high
seropositivity among older subjects and they speculated the waning
antibodies to CHIKV as a possible reason for the subsequent
outbreak [42]. More studies need to be undertaken to prove this
hypothesis and to further address the susceptibility of the Delhi
populace to chikungunya infection. This is supported by reports of
periodic outbreaks of dengue fever in Delhi every 3–4 years [39].
Chikungunya fever has been observed to occur mostly during
the monsoon and post monsoon seasons during which time there is
high breeding of both Aedes albopictus and Aedes aegypti. In India the
first CHIKV outbreak in 1963 was observed during July to
December, coinciding with the monsoon and post monsoon
seasons. However, in the present study, CHIKV was detected
throughout the year at KIMS centre although with higher rate
during the monsoon season, a situation similar to dengue [39].
Our study has confirmed the findings of various other studies
that certain symptoms like rashes, headache, joint pain/swelling
and abdominal pain are significantly associated with chikungunya
infections [12,13,31,32].
Figure 2. Age distribution of chikungunya patients at hospitals in Karnataka and Rajasthan, June 2008 through May 2009.
doi:10.1371/journal.pone.0030025.g002
Table 4. Comparison of clinical symptoms among chikungunya positive patients of different age groups.
Symptoms Age groups p value* Odds Ratio (95% CI)*
0–5 years (n=17) .5–18 years (n=45) .18 years (n=75)
Rash 5 (29.41%) 15 (33.33%) 48 (64%) 0.0002 3.73(1.83–7.60)
Headache 6 (35.29%) 26 (57.78%) 72 (96%) ,0.0001 22.5 (6.4–79.14)
Joint Pain 11 (64.71%) 32 (71.11%) 74 (98.67%) ,0.0001 32.7 (4.23–252.9)
Joint Swelling 4 (23.53%) 10 (22.22%) 55 (73.33%) ,0.0001 9.43 (4.3–20.67)
Abdominal Pain 10 (58.82%) 27 (60%) 49 (65.33%) .0.05 1.27 (0.63–2.55)
Vomiting 8 (47.06%) 27 (60%) 36 (48%) .0.05 0.71 (0.36–1.4)
Note. Data are no. (%) of patients.
*P value and Odds ratio was calculated using chi square test between patients of .18 years and up to 18 years of age.
doi:10.1371/journal.pone.0030025.t004
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adults as compared to children confirms most of those reported
worldwide [11,12,31,37]. In addition we found adults more
frequently exhibiting symptoms such as rashes, headache, joint
pain and joint swelling as compared to children [38]. Interestingly
among rashes, erythrematous rash was frequently observed in
adults while maculopapular rash was common in children
confirming earlier reports in infants [43,44]. Another interesting
observation made in our study was the higher incidence of
hepatomegaly among children aged below 5 years. Support for
this result can be found in a recent pathogenesis study in mice that
demonstrated hepatic involvement during chikungunya infection
Figure 3. Phylogenetic analysis of the E1 gene (nt 10246 to 11158) of chikungunya strains from adults (shown in closed circles) and
children (shown in straight closed triangles). The tree was constructed using the neighbor-joining method with 1000 bootstrap resamplings
and rooted with the E1 gene of the O’nyong-nyong virus. Reference sequences were obtained from the GenBank and EMBL databases; accession
numbers are given in parentheses.
doi:10.1371/journal.pone.0030025.g003
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the muscle and joints [45]. In addition, a recent review reported
many atypical symptoms including raised levels of hepatic
enzymes associated with chikungunya infection [25].
In addition to assessing clinical and epidemiological implications
of chikungunya we tried to identify the molecular composition of
the infecting strains. High nucleotide and amino acid homology
was observed among the infecting strains which clustered within
the Central/East African genotype confirming earlier reports that
all recent CHIKV outbreaks in India have been a result of the
Central/East African genotype [7,37]. This is markedly different
from the CHIKV strains that caused the outbreak in India during
1963–73 that resulted from the Asian genotype [46]. Our study
also confirms earlier reports on the presence of A226V mutation in
the E1 gene [24,26,34]. It has been suggested that a change in the
amino acid at this particular position may provide a selective
advantage for CHIKV transmission by mosquitoes by reducing
their cholesterol dependence [6,47]. Our study also observed a
lysine-glutamine change at aa 132 in the E1 gene of CHIKV
infecting children, an implication that warrants further investiga-
tion.
In conclusion, to our knowledge this is the first multi-centre
study undertaken to determine the epidemiology of chikungunya
fever across a wide age group with year round enrolment of large
number of patients simultaneously in three different geographical
regions of India. Both genomic and serology based assays were
employed throughout the study for confirmation of CHIKV. Our
study clearly demonstrates high incidence of CHIKV in India
particularly in the southern region with moderate prevalence in
the western and rare in the northern region. This warrants
continuous CHIKV surveillance in India to determine the disease
burden for improved healthcare.
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